| Dr Oscar Luis Corral, DPM | |
|
812 Lindberg Ave, Complete Family Foot Care, Mcallen, TX 78501 | |
| (956) 971-9107 | |
| (956) 971-9109 |
| Full Name | Dr Oscar Luis Corral |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 22 Years |
| Location | 812 Lindberg Ave, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609869486 | NPI | - | NPPES |
| 183306301 | Medicaid | TX | |
| 4661430001 | Other | TX | PALMETTO DME FACILITY GROUP |
| 1609869486 | Other | TX | NPI INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1761 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rio Grande Regional Hospital | Mcallen, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joseph M Caporusso Dpm Pa | 2264490465 | 6 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
A collaborative team between the University of Minnesota Medical School and Van Andel Institute will soon begin a $6.2 million study that seeks to define the molecular linkages between aging and Parkinson's disease - an approach for new treatment targets not yet explored by many researchers.
In the light of her research showing that adults with learning disabilities were 58 times more likely to die before the age of 50 than the rest of the population, Professor Sheila Hollins has been appointed by Health Secretary Patricia Hewitt to an independent inquiry into unequal health outcomes for people with learning disabilities.
Young, healthy adult volunteers exposed for two hours to ozone developed physiological changes associated with cardiovascular ailments, according to a small study reported in Circulation, an American Heart Association journal.
As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.
› Verified 8 days ago
| Provider Name | Su Clinica Familiar |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285643304 PECOS PAC ID: 5496663429 Enrollment ID: O20040121001155 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
A collaborative team between the University of Minnesota Medical School and Van Andel Institute will soon begin a $6.2 million study that seeks to define the molecular linkages between aging and Parkinson's disease - an approach for new treatment targets not yet explored by many researchers.
In the light of her research showing that adults with learning disabilities were 58 times more likely to die before the age of 50 than the rest of the population, Professor Sheila Hollins has been appointed by Health Secretary Patricia Hewitt to an independent inquiry into unequal health outcomes for people with learning disabilities.
Young, healthy adult volunteers exposed for two hours to ozone developed physiological changes associated with cardiovascular ailments, according to a small study reported in Circulation, an American Heart Association journal.
As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.
› Verified 8 days ago
| Provider Name | Joseph M Caporusso Dpm Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255401196 PECOS PAC ID: 2264490465 Enrollment ID: O20041220000808 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
A collaborative team between the University of Minnesota Medical School and Van Andel Institute will soon begin a $6.2 million study that seeks to define the molecular linkages between aging and Parkinson's disease - an approach for new treatment targets not yet explored by many researchers.
In the light of her research showing that adults with learning disabilities were 58 times more likely to die before the age of 50 than the rest of the population, Professor Sheila Hollins has been appointed by Health Secretary Patricia Hewitt to an independent inquiry into unequal health outcomes for people with learning disabilities.
Young, healthy adult volunteers exposed for two hours to ozone developed physiological changes associated with cardiovascular ailments, according to a small study reported in Circulation, an American Heart Association journal.
As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Oscar Luis Corral, DPM 812 Lindberg Ave, Mcallen, TX 78501 Ph: (956) 971-9107 | Dr Oscar Luis Corral, DPM 812 Lindberg Ave, Complete Family Foot Care, Mcallen, TX 78501 Ph: (956) 971-9107 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc., have completed settlement agreements with six out of eight defendants in patent infringement litigation brought against these parties in response to their Abbreviated New Drug Applications for generic ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin HCl). Takeda recently concluded litigation with the sixth settling defendant.
A collaborative team between the University of Minnesota Medical School and Van Andel Institute will soon begin a $6.2 million study that seeks to define the molecular linkages between aging and Parkinson's disease - an approach for new treatment targets not yet explored by many researchers.
In the light of her research showing that adults with learning disabilities were 58 times more likely to die before the age of 50 than the rest of the population, Professor Sheila Hollins has been appointed by Health Secretary Patricia Hewitt to an independent inquiry into unequal health outcomes for people with learning disabilities.
Young, healthy adult volunteers exposed for two hours to ozone developed physiological changes associated with cardiovascular ailments, according to a small study reported in Circulation, an American Heart Association journal.
As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.
› Verified 8 days ago
Robert C Brace Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 533 Pecan Blvd, Mcallen, TX 78501 Phone: 956-682-4187 Fax: 956-682-9739 | |
Dr. Bryan J Prukop, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 812 Lindberg Ave, Mcallen, TX 78501 Phone: 956-971-9107 Fax: 956-971-9109 | |
Complete Family Foot Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 812 Lindberg Ave, Mcallen, TX 78501 Phone: 956-971-9107 Fax: 956-971-9109 | |
Dr. Juan Netzahualcoyotl Gonzalez, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 713 N Ware Rd, Mcallen, TX 78501 Phone: 956-682-8496 Fax: 956-682-0590 | |
Complete Family Foot Care Podiatrist Medicare: Medicare Enrolled Practice Location: 812 Lindberg Ave, Mcallen, TX 78501 Phone: 956-971-9107 Fax: 956-776-0902 | |
Dr. Joseph F Bender, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 812 Lindberg Ave, Mcallen, TX 78501 Phone: 956-971-9107 Fax: 956-971-9109 | |
Dr. Serei Y Lee, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 713 N Ware Rd, Mcallen, TX 78501 Phone: 956-682-8496 Fax: 956-682-0590 |